Lisa Argnani (L Argnani)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Systematic Review

Epstein Barr Virus

Chronic Lymphocytic Leukemia

Top Venues

Annals of hematology

Leukemia & lymphoma

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Rossana Di Staso, Beatrice Casadei, Marianna Gentilini, Serafina Guadagnuolo, Cinzia Pellegrini, Alessandro Broccoli, Davide Gori, Riccardo Masetti, Vittorio Stefoni, Francesca Bonifazi, Pier Luigi Zinzani, Lisa Argnani
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity. Annals of hematology 103 (7) (2024)
Rossana Di Staso, Beatrice Casadei, Marianna Gentilini, Serafina Guadagnuolo, Cinzia Pellegrini, Alessandro Broccoli, Davide Gori, Riccardo Masetti, Vittorio Stefoni, Francesca Bonifazi, Pier Luigi Zinzani, Lisa Argnani
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity. Annals of hematology (2024)
Rossana Di Staso, Beatrice Casadei, Marianna Gentilini, Serafina Guadagnuolo, Cinzia Pellegrini, Alessandro Broccoli, Davide Gori, Riccardo Masetti, Vittorio Stefoni, Francesca Bonifazi, Pier Luigi Zinzani, Lisa Argnani
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity. Annals of hematology 103 (7) (2024)
Rossana Di Staso, Beatrice Casadei, Marianna Gentilini, Serafina Guadagnuolo, Cinzia Pellegrini, Alessandro Broccoli, Davide Gori, Riccardo Masetti, Vittorio Stefoni, Francesca Bonifazi, Pier Luigi Zinzani, Lisa Argnani
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity. Annals of hematology 103 (7) (2024)
Beatrice Casadei, Gabriele Conti, Monica Barone, Silvia Turroni, Serafina Guadagnuolo, Alessandro Broccoli, Patrizia Brigidi, Lisa Argnani, Pier Luigi Luigi Zinzani
Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors-The MicroLinf Study. Hematological oncology 42 (5) (2024)
Rossana Di Staso, Beatrice Casadei, Marianna Gentilini, Serafina Guadagnuolo, Cinzia Pellegrini, Alessandro Broccoli, Davide Gori, Riccardo Masetti, Vittorio Stefoni, Francesca Bonifazi, Pier Luigi Zinzani, Lisa Argnani
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity. Annals of hematology 103 (7) (2024)
Lisa Argnani, Beatrice Casadei, Carla Pelusi, Valentina Lo Preiato, Uberto Pagotto, Francesco Bertoni, Pier Luigi Zinzani
Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitors. Scientific reports 12 (1) (2022)
Ginevra Lolli, Margherita Ursi, Michele Dicataldo, Beatrice Casadei, Gianluca Storci, Lisa Argnani, Francesca Bonifazi, Pier Luigi Luigi Zinzani
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient. Leukemia & lymphoma 63 (12) (2022)
Greta Carrara, Lisa Argnani, Anna Zanetti, A Zabotti, Alen Zabotti, Gian Domenico Sebastiani, Marco Sebastiani, And Carlo Alberto Scirè
Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology. Scandinavian journal of rheumatology 51 (5) (2022)
Beatrice Casadei, Lisa Argnani, Alessandro Broccoli, Caterina Patti, Piero Maria Stefani, Antonio Cuneo, Gloria Margiotta Casaluci, Chiara Rusconi, Guido Gini, Fabrizio Pane, Francesco D'Alò, Debora Luzi, Maria Cantonetti, Samantha Pozzi, Gerardo Musuraca, Chiara Rosignoli, Annalisa Arcari, Sofya Kovalchuk, Monica Tani, Maria Chiara Tisi, Mario Petrini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study. Cancers 14 (3) (2022)
Anna Myriam Perrone, Gloria Ravegnini, Stefano Miglietta, Lisa Argnani, Costanza Maria Donati, Eugenia De Crescenzo, Marco Tesei, Marco Di Stanislao, Giulia Girolimetti, Giuseppe Gasparre, Anna Maria Porcelli, Francesca De Terlizzi, Claudio Zamagni, Alessio Giuseppe Morganti, Pierandrea De Iaco
Electrochemotherapy in Vulvar Cancer and Cisplatin Combined with Electroporation. Systematic Review and In Vitro Studies. Cancers 13 (9) (2021)
Beatrice Casadei, Lisa Argnani, Serafina Guadagnuolo, Cinzia Pellegrini, Vittorio Stefoni, Alessandro Broccoli, Laura Nanni, Alice Morigi, Ginevra Lolli, Maria Guarino, Luca Spinardi, Elisabetta Pierucci, Stefano Fanti, Michele Bartoletti, Michele Dicataldo, Sabattini Elena, Francesca Bonifazi, Pier Luigi Luigi Zinzani
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience. Cancers 13 (19) (2021)
Chiara Tarantelli, Lisa Argnani, Pier Luigi Luigi Zinzani, Francesco Bertoni
PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients. Cancers 13 (21) (2021)
Paolo Elia Coppola, Alessandro Broccoli, Lisa Argnani, Beatrice Casadei, Vittorio Stefoni, Clara Bertuzzi, Elena Sabattini, Pier Luigi Luigi Zinzani
Rapid but reversible progression and transformation of chronic lymphocytic leukemia after temporary ibrutinib discontinuation due to off-target toxicity: two interesting cases. Leukemia & lymphoma (2021)
Alessandro Broccoli, Lisa Argnani, Alice Morigi, Laura Nanni, Beatrice Casadei, Cinzia Pellegrini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life Experience. Journal of clinical medicine 10 (24) (2021)
Alessandro Broccoli, Clara Bertuzzi, Michelangelo Fiorentino, Alice Morigi, Vittorio Stefoni, Claudio Agostinelli, Lisa Argnani, Michele Cavo, Pier Luigi Luigi Zinzani
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia. OncoTargets and therapy 12 (2019)